For the Quarter Ending March 2026
Itraconazole Prices in North America
- In United States, the Itraconazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Itraconazole Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0% year-over-year.
- Consumer Price Index inflation of 3.3% in March 2026 elevated transportation and operational expenses for Itraconazole distribution.
- The Itraconazole Demand Outlook remained stable in March 2026, supported by resilient retail sales growth of 4.0%.
- A stable unemployment rate of 4.3% in March 2026 sustained patient affordability and steady Itraconazole market consumption.
- The Manufacturing Index expanded in March 2026, ensuring robust production of pharmaceutical excipients for Itraconazole dosage forms.
- Industrial production grew a modest 0.7% in March 2026, tightening supply margins for energy-intensive Itraconazole API synthesis.
- The Itraconazole Price Forecast reflected upward trends in Q1 2026 as consumer confidence reached 91.8 in March 2026.
Why did the price of Itraconazole change in March 2026 in North America?
- Itraconazole prices increased in March 2026 because toluene and benzene feedstock costs surged amid energy market volatility.
- Domestic chemical feedstock inventories tightened significantly in March 2026 due to shipping restrictions and supply chain pressures.
- United States imports of pharmaceutical preparations weakened in Jan 2026, further constraining the available Itraconazole market supply.
Itraconazole Prices in APAC
- In China, the Itraconazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- The Itraconazole Production Cost Trend increased as the Producer Price Index rose 0.5% in March 2026.
- The Itraconazole Demand Outlook remained stable for essential medications as consumer inflation reached 1.0% in March 2026.
- Discretionary veterinary demand declined as unemployment hit 5.4% in March 2026 and consumer confidence reached 91.6 in February 2026.
- Muted retail sales growth of 1.7% in March 2026 further dampened out-of-pocket healthcare spending for Itraconazole.
- Strong industrial production growth of 5.7% and an expanding Manufacturing Index in March 2026 ensured abundant supply.
- Upstream pure benzene prices surged throughout March 2026, directly elevating baseline production costs for Itraconazole.
- China experienced surging naphtha imports during January-February 2026 as domestic supply struggled to match downstream demand.
- The Itraconazole Price Forecast reflected upward momentum in Q1 2026 due to elevated crude oil futures.
Why did the price of Itraconazole change in March 2026 in APAC?
- Import costs for naphtha spiked in Q1 2026 due to escalating international geopolitical tensions.
- Market prices for pure benzene fluctuated and ultimately surged throughout March 2026, increasing production costs.
- International crude oil futures continued to strengthen through March 2026, elevating baseline petrochemical feedstock expenses.
Itraconazole Prices in Europe
- In Germany, the Itraconazole Price Index fell quarter-over-quarter in Q1 2026, driven by plummeting precursor costs.
- Consumer inflation rose 2.7% in March 2026, while producer prices declined 0.2% during the same period.
- The Manufacturing Index expanded in March 2026, despite stagnant industrial production at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment remained low at 4.2% in February 2026, supporting healthcare spending.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting the overall Itraconazole Demand Outlook.
- The Itraconazole Production Cost Trend declined as key benzene precursor costs plummeted significantly in March 2026.
- European natural gas spot prices surged and naphtha feedstock costs strengthened notably in March 2026.
- Raw material imports faced severe logistical disruptions in March 2026 due to Strait of Hormuz closures.
- The Itraconazole Price Forecast indicated continued downward pressure throughout Q1 2026 amid weakened pharmaceutical sector demand.
Why did the price of Itraconazole change in March 2026 in Europe?
- Benzene precursor costs plummeted in March 2026, directly reducing overall pharmaceutical active ingredient manufacturing expenses.
- Underlying demand for key precursors weakened in March 2026 due to poor overall market fundamentals.
- Asian chemical import volumes faced severe logistical disruptions in March 2026, altering regional supply availability.
For the Quarter Ending December 2025
Itraconazole Prices in North America
- In United States, the Itraconazole Price Index rose quarter-over-quarter in Q4 2025, driven by robust demand and increasing production costs.
- Itraconazole production costs increased in Q4 2025, influenced by a 2.7% CPI rise in December and 3.0% PPI increase in November.
- Demand for Itraconazole strengthened in Q4 2025, supported by 3.3% retail sales growth in November and 4.4% unemployment in December.
- Healthcare sector demand for pharmaceuticals was bolstered in 2025 by chronic disease prevalence and demographic aging.
- Industrial electricity costs for the US industrial sector strengthened in November 2025, raising Itraconazole manufacturing expenses.
- US industrial production increased by 2.0% year-over-year in December 2025, indirectly supporting pharmaceutical demand.
- Manufacturing firms accumulated inventories in December 2025, though at a decelerated pace from November.
- Consumer confidence of 89.1 in December 2025 indicated moderate optimism, supporting healthcare spending and pharmaceutical demand.
Why did the price of Itraconazole change in December 2025 in North America?
- Rising input costs, including a 2.7% CPI increase in December 2025, elevated Itraconazole production expenses.
- Strong consumer spending, with retail sales up 3.3% in November 2025, bolstered demand for pharmaceutical products.
- Increased industrial electricity costs in November 2025 contributed to higher manufacturing overhead for Itraconazole producers.
Itraconazole Prices in APAC
- In China, the Itraconazole Price Index fell quarter-over-quarter in Q4 2025, influenced by weak consumer demand and increased supply.
- Itraconazole production costs saw mixed trends, with raw material input costs accelerating in December 2025.
- The Producer Price Index (PPI) declined by -1.9% year-on-year in December 2025, indicating lower overall producer costs.
- Itraconazole demand was subdued due to a low Consumer Price Index (CPI) of 0.8% in December 2025.
- Retail sales growth was low at 0.9% year-on-year in December 2025, reflecting cautious consumer spending.
- China's Manufacturing Index returned to expansion in December 2025, supporting overall economic activity.
- Industrial Production rose by 5.2% year-on-year in December 2025, indicating a robust manufacturing sector.
- Pharmaceutical exports from China steadily increased in 2025, redirecting volumes to ASEAN, European, and African markets.
- Sufficient raw material inventories were reported in December 2025, contributing to stable supply.
Why did the price of Itraconazole change in December 2025 in APAC?
- Weak consumer demand, evidenced by a low 0.8% CPI and 0.9% retail sales growth in December 2025.
- Producer Price Index declined by -1.9% in December 2025, suggesting lower manufacturing input costs.
- Increased pharmaceutical exports and significant production capacity contributed to market supply in 2025.
Itraconazole Prices in Europe
- In Germany, the Itraconazole Price Index fell quarter-over-quarter in Q4 2025, driven by declining producer prices.
- Itraconazole production costs declined in December 2025, influenced by a -2.5% PPI fall and marked energy price reductions.
- Itraconazole demand outlook was mixed in Q4 2025, with pharmaceutical market outperformance contrasting contracting manufacturing activity.
- Consumer confidence remained low at -17.5 in December 2025, dampening discretionary spending on Itraconazole applications.
- German exports declined in Q4 2025, while the chemical industry's order backlog worsened in October 2025.
- Industrial production grew 0.8% in October 2025, yet chemical production showed a steeper decline.
- The unemployment rate of 6.2% in December 2025 and 1.8% CPI increase impacted consumer purchasing power.
- Itraconazole price forecast suggests continued stability or slight downward pressure, influenced by cost trends.
Why did the price of Itraconazole change in December 2025 in Europe?
- Producer prices declined -2.5% year-on-year in December 2025, reducing manufacturing input costs.
- Energy and natural gas prices significantly declined in December 2025, lowering production expenses.
- Contracting manufacturing activity and low consumer confidence (-17.5) impacted demand in December 2025.
For the Quarter Ending September 2025
Itraconazole Prices in North America
- In the United States, Itraconazole Price Index rose in Q3 2025, driven by strengthening pharmaceutical demand and rising input costs.
- Itraconazole production costs increased during Q3 2025, influenced by a 2.6% year-over-year PPI rise in August 2025.
- Demand for Itraconazole strengthened in Q3 2025, supported by increased FDA drug approvals in the pharmaceutical sector.
- The Itraconazole Price Index faced upward pressure from firming feedstock costs and robust sector demand in Q3 2025.
- Rising CPI (3.0% year-over-year in September 2025) signaled higher operational costs; consumer confidence also declined.
- Strong retail sales (5.42% year-over-year in September 2025) and low unemployment (4.3% in September 2025) supported healthcare spending.
- Natural gas prices, a key methanol feedstock, reached a two-year high in Q3 2025, impacting production costs.
- Industrial production saw a marginal 0.1% year-over-year increase in September 2025, indicating broader economic stagnation.
Why did the price of Itraconazole change in September 2025 in North America?
- Rising input costs, with PPI increasing 2.6% year-over-year in August 2025, pressured Itraconazole prices upward.
- Strengthening US pharmaceutical sector demand in Q3 2025, driven by new drug approvals, supported Itraconazole price increases.
- Higher natural gas prices in Q3 2025, impacting methanol feedstock, increased Itraconazole production expenses.
Itraconazole Prices in Europe
- In Germany, the Itraconazole Price Index fell in Q3 2025, due to easing basic chemical producer prices and intensified imports.
- Itraconazole production costs faced upward pressure from elevated overall raw material and high energy costs in Q3 2025.
- Demand for pharmaceutical products in Germany strengthened in Q3 2025, supporting the Itraconazole demand outlook.
- The Manufacturing Index showed a contracting trend in September 2025, reflecting a broader slowdown in German industrial activity.
- Industrial Production in Germany declined by 1.0% year-over-year in September 2025, impacting overall supply chain stability.
- Consumer Price Index rose 2.4% year-over-year in September 2025, while Producer Price Index declined 1.7%.
- Unemployment remained low at 3.9% in September 2025, supporting consumer spending and healthcare demand.
- High carbon allowance costs continued to pressure European chemical companies, influencing Itraconazole price forecasts in Q3 2025.
Why did the price of Itraconazole change in September 2025 in Europe?
- Producer Price Index declined 1.7% in September 2025, easing basic chemical input costs.
- Imports of pharmaceutical products into Germany intensified in Q3 2025, increasing overall supply.
- Elevated raw material and high energy costs continued to pressure Itraconazole production expenses in Q3 2025.
Itraconazole Prices in APAC
- In China, the Itraconazole Price Index declined quarter-over-quarter in Q3 2025, driven by persistent industry overcapacity.
- The Itraconazole Price Forecast suggests continued downward pressure, influenced by cautious consumer confidence in September 2025.
- Itraconazole Production Cost Trend saw input cost inflation ease in September 2025, following August's raw material price increases.
- Itraconazole Demand Outlook remained subdued in Q3 2025, despite strengthening demand for specialty chemicals.
- The Itraconazole Price Index faced bearish pressure from a contracting Manufacturing Index in September 2025.
- China's CPI declined by 0.3% year-on-year in September 2025, indicating broader deflationary pressures.
- PPI fell by 2.3% year-on-year in September 2025, reducing factory-gate prices for Itraconazole manufacturers.
- Industrial production expanded by 6.5% year-on-year in September 2025, supporting stable supply chains.
- Stable retail sales, up 3.0% year-on-year in September 2025, indirectly supported healthcare funding.
- A stable unemployment rate of 5.2% in September 2025 supported consumer income and healthcare access.
Why did the price of Itraconazole change in September 2025 in APAC?
- China's CPI declined by 0.3% in September 2025, signaling overall deflationary pressures.
- The Manufacturing Index contracted in September 2025, reflecting economic weakness and subdued demand.
- Persistent overcapacity in China's chemical industry throughout Q3 2025 amplified supply.
For the Quarter Ending December 2022
North America
- The Itraconazole market in the North American region fluctuated in the fourth quarter of 2022. Prices started to rise in Q4 2022 and kept growing due to high manufacturing costs, numerous logistical problems, and rising inflation through the second month of the fourth quarter.
- Growing transportation costs and congestion at the key ports also helped maintain the market position. Furthermore, confusion and a slowdown in API output due to rising energy prices had a favorable effect on the market. Prices begin to decrease later in December as a result of falling inflation and decreasing end-user sector demand as the holiday season approaches. Towards the termination of Q4 2022, the prices of itraconazole API accessed at USD 366560/MT with an average quarterly inclination of 0.12%.
Asia
- The Asia Pacific region experienced generally unchanged market sentiments for the itraconazole API during the fourth quarter of 2022. Due to strong demand from downstream pharmaceutical businesses, prices started to rise steadily at the beginning of the fourth quarter. Zero-covid policies and the installation of lockdowns both had an impact on the market environment. Later, as Q4 2022's second month got underway, lower production costs, sufficient stockpiles, and a strong supply caused the itraconazole API price trajectory to exhibit a stable trend. The domestic market was also sustained by steady end-user demand. Towards the termination of Q4 2022, the itraconazole API market prices were recoded as USD 345200/MT FOB Shanghai with an average quarterly inclination of 0.53%.
Europe
- Itraconazole pricing in the European region exhibited a see-saw trend in the fourth quarter of 2022. The demand for itraconazole API in the pharmaceutical industry's downstream market was seen to be steady. In the first two months of Q4 2022, price increases were caused by the continuous port congestion and supply disruption in the European region. The trend of itraconazole was also impacted by increased freight costs. However, due to a decline in inflation, relief from port congestion, and a small amount of inventory held by domestic retailers, prices fell significantly in the month of December. Towards the termination of Q3 2022, the Itraconazole API market prices were recoded as USD 371820/MT CFR Hamburg with an average quarterly inclination of 0.12%.
